Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionVerition Fund Management LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Verition Fund Management LLC ownership in JAZZ / Jazz Pharmaceuticals plc

On May 15, 2026 - Verition Fund Management LLC filed a 13F-HR form disclosing ownership of 0 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 40,590 shares of Jazz Pharmaceuticals plc. The current value of the position is $0 USD.

Verition Fund Management LLC has a history of taking positions in derivatives of the underlying security (JAZZ) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

JAZZ / Jazz Pharmaceuticals plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -100.00 0
2026-02-13 2025-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 40,590 13,291 48.69 6,900 91.77 0.0271
2025-11-14 2025-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 27,299 -5,397 -16.51 3,598 3.72 0.0149
2025-08-14 2025-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 32,696 -219,783 -87.05 3,470 -88.93 0.0154
2025-05-15 2025-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 252,479 239,319 1,818.53 31,345 1,834.88 0.1460
2025-02-14 2024-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 13,160 13,160 1,621 0.0064
2024-05-14 2024-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -3,737 -100.00 0 -100.00
2024-02-14 2023-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 3,737 3,737 460 0.0036
2023-08-14 2023-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -10,330 -100.00 0 -100.00
2023-05-15 2023-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 10,330 8,324 414.96 1,512 373.67 0.0209
2023-02-14 2022-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 2,006 -2,368 -54.14 320 -45.28 0.0050
2023-01-18 2022-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 4,374 2,956 208.46 583 163.80 0.0065
2022-11-14 2022-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 4,374 2,956 583 0.0066
2022-08-30 2022-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 1,418 -49,712 -97.23 221 -97.22 0.0044
2022-08-15 2022-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 1,418 -49,712 221 0.0044
2022-06-02 2022-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 51,130 -30,608 -37.45 7,959 -23.57 0.0956
2022-05-13 2022-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 51,130 -30,608 7,959 0.0957
2022-05-03 2021-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 81,738 50,875 164.84 10,413 159.09 0.0712
2022-02-14 2021-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 42,176 11,313 5,373 0.0348
2021-11-15 2021-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 30,863 30,863 4,019 0.0348
2020-08-14 2020-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -2,801 -100.00 0 -100.00
2020-05-15 2020-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 2,801 1,187 73.54 279 15.77 0.0110
2020-02-14 2019-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 1,614 1,614 241 0.0044
2019-11-14 2019-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,690 -100.00 0 -100.00
2019-08-14 2019-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,690 -136 -1.06 1,809 -1.31 0.0509
2019-05-15 2019-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,826 7,453 138.71 1,833 175.23 0.0714
2019-02-14 2018-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 5,373 -10,336 -65.80 666 -74.78 0.0478
2018-11-14 2018-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 15,709 -7,583 -32.56 2,641 -34.19 0.0945
2018-08-15 2018-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 23,292 3,014 14.86 4,013 31.06 0.2450
2018-05-15 2018-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 20,278 20,278 3,062 0.2277
2017-11-14 2017-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,600 -100.00 0 -100.00
2017-08-15 2017-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,600 12,600 1,959 0.1904
2017-05-12 2017-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -7,036 -100.00 0 -100.00
2017-02-14 2016-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 7,036 7,036 0.00 767 0.0662
2016-11-15 2016-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -16,789 -100.00 0 -100.00
2016-08-15 2016-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 16,789 16,789 0.00 2,372 0.3027
2015-11-13 2015-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,152 -100.00 0 -100.00
2015-08-14 2015-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,152 4,992 69.72 2,140 73.00 0.3750
2015-05-15 2015-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 7,160 7,160 57.12 1,237 295.21 0.1437
2013-11-14 2013-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -4,557 -100.00 0 -100.00
2013-08-12 2013-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 4,557 4,557 313 0.0574
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-08-30 2022-06-30 13F/A JAZZ PHARMACEUTICALS SHS USD Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F JAZZ PHARMACEUTICALS SHS USD Call 0 0 n/a n/a n/a
2022-06-02 2022-03-31 13F/A JAZZ PHARMACEUTICALS SHS USD Call 13,500 2,102 n/a n/a n/a
2022-05-13 2022-03-31 13F JAZZ PHARMACEUTICALS SHS USD Call 13,500 2,102 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-14 2018-09-30 13F JAZZ PHARMACEUTICALS SHS USD Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-15 2018-06-30 13F JAZZ PHARMACEUTICALS SHS USD Put 5,200 896 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.